Literature DB >> 25364991

Psilocybin and Obsessive Compulsive Disorder.

James Allen Wilcox1.   

Abstract

Obsessive Compulsive Disorder (OCD) is a psychiatric disorder with considerable morbidity and mortality. This condition disables many individuals and is often refractory to treatment. Research suggests that serotonin plays a role in OCD symptom reduction. We present a case of an individual who successfully used psilocybin, a serotonergic agent, to reduce the core symptoms of OCD for several years. Although not endorsing this form of treatment, we feel that the successful use of this agent highlights the role of serotonergic factors in OCD and the need for further, legitimate research into the value of psilocybin in the treatment of anxiety disorders.

Entities:  

Keywords:  anxiety; obsessive compulsive; psilocybin; psychedelic

Mesh:

Substances:

Year:  2014        PMID: 25364991     DOI: 10.1080/02791072.2014.963754

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  8 in total

Review 1.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

2.  Clinical potential of psilocybin as a treatment for mental health conditions.

Authors:  Jeremy Daniel; Margaret Haberman
Journal:  Ment Health Clin       Date:  2018-03-23

3.  The good, the bad and the tasty: The many roles of mushrooms.

Authors:  K M J de Mattos-Shipley; K L Ford; F Alberti; A M Banks; A M Bailey; G D Foster
Journal:  Stud Mycol       Date:  2016-11-11       Impact factor: 16.097

Review 4.  What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review.

Authors:  Henrique Castro Santos; João Gama Marques
Journal:  Porto Biomed J       Date:  2021-02-11

5.  Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Authors:  Joseph M Peill; Katie E Trinci; Hannes Kettner; Lea J Mertens; Leor Roseman; Christopher Timmermann; Fernando E Rosas; Taylor Lyons; Robin L Carhart-Harris
Journal:  J Psychopharmacol       Date:  2022-01-05       Impact factor: 4.153

Review 6.  Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?

Authors:  Maurizio Coppola; Francesco Bevione; Raffaella Mondola
Journal:  J Xenobiot       Date:  2022-02-07

Review 7.  The Therapeutic Potential of Psilocybin.

Authors:  Henry Lowe; Ngeh Toyang; Blair Steele; Henkel Valentine; Justin Grant; Amza Ali; Wilfred Ngwa; Lorenzo Gordon
Journal:  Molecules       Date:  2021-05-15       Impact factor: 4.411

Review 8.  Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jaime E C Hallak
Journal:  Braz J Psychiatry       Date:  2016-03       Impact factor: 2.697

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.